Indian Journal of Rheumatology 2011 March

PG Forum
Volume 6, Number 1; p. 40

Rheumatology quiz
Downloaded from http://journals.lww.com/ijru by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AW

Vivek Arya, Varun Dhir

nYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 03/17/2023

1. Long-term remission rates in Behcet’s disease associ- 6. Atypical femoral fractures seen in patients taking bis-
ated uveitis are highest with phosphonates most commonly affect the
(a) azathioprine (a) shaft
(b) corticosteroids (b) neck
(c) interferon α (c) lower end
(d) cyclosporine A (d) subtrochanteric region
2. In early secondary Raynaud’s phenomenon, nail fold 7. The lesions of urticarial vasculitis differ from those of
capillaroscopy shows urticaria in their
(a) increased capillary size (a) size
(b) microhaemorrhages (b) location
(c) loss of capillaries (c) morphology
(d) neoangiogenesis (d) time to resolution
3. Levels of which of these markers are elevated in the 8. The drug which has shown promise in treating
early nail fold capillaroscopy changes of PSS? osteonecrosis of the jaw following bisphosphonate use is
(a) anti-Scl 70 antibodies (a) rituximab
(b) anti-centromere antibodies (b) teriparatide
(c) serum tissue kallikrein (c) cholecalciferol
(d) urinary F2-isorostanes (d) methotrexate
4. Which of the following is not a feature of dermato- 9. All the following are seen in Wegener’s granulomatosis,
myositis associated with anti-Mi-2 antibodies? except
(a) acute onset (a) deficiency of TREG cells
(b) V-sign, shawl sign rashes are common (b) decreased expression of CD25 on T cells
(c) cuticular overgrowth (c) shift from CD4+ to CD8+ T cells
(d) poor response to treatment (d) skewing towards CD4+ effector memory cells
5. Factors associated with severe infections one year fol- 10. Which of the following indices is used in the
lowing the first cycle of rituximab in RA include all, ACR/EULAR provisional definition of remission in
except rheumatoid arthritis for clinical trials?
(a) older age (a) DAS28
(b) extra-articular involvement (b) MOI-RA
(c) anti-CCP positivity (c) SDAI
(d) low IgG levels (d) CDAI
For answers refer page 43